CYTIN

pharmaceutical preparation for recombinant forms of placental protein for the treatment of immunological disorders, allergic conditions, autoimmune conditions, inflammatory conditions, lymphoproliferation disorders, neoplastic disorders, cancer, gastrointestinal disorders, dermatological disorders, and predicting the possibility of miscarriages, preventing miscarriages, and improving the efficacy of assisted reproductive techniques